You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease

Citation Tools

Article menu

Download PDFPDF

Epidemiology
Original research
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Frommert LM, Arumahandi de Silva AN, Zernicke J, et al
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease
RMD Open 2022;8:e002650. doi: 10.1136/rmdopen-2022-002650